2 points:
https://www.frontiersin.org/articles/10.3389/fimmu.2019.00438/full
https://en.wikipedia.org/wiki/Somatic_hypermutation
First point --
The links explain Somatic Hypermutation (SHM) in the immune system, specifically in antigen-activated germinal center B cells. Germinal centers are in lymph nodes The Bcells there are involved in affinity maturation - a map for antigen Ig synthesis.
What does this mean?
SHM is specifically designed to keep up with possible antigen changes in pathogens. e.g., Delta, Omicron at al.
A. it works well only after maturation - many weeks after exposure. Time required may vary with the pathogen, diet, and other problems like inflammatory diseases example: Lupus, Type II diabetes,
B. function is marked improved with multiple exposures to antigens i.e. boosters. Over extended time.
C. This not like the very first response we see in newly immunized patients.
D. So, after several months the response is to prevent disease even from variants. NOT infection.
E. Immunocompromised patients do not do SHM well, which may be why some physicians may have administered more than three Covid vaccines to this patient population. Second point --
A. Vaccines are designed from the get-go to depend primarily on SHM.
B. Vaccines are unusual if they provide "upfront" protection from infection
C. Covid mRNA vaccines do protect against infection. Upfront. Even though they do the SHM thing as well.
D. Some Covid vaccines (like AstraZeneca) do not use mRNA. So, infection protection is not like mRNA vaccines.
E. Infection protection induced by a few vaccines wanes. But for Covid we are expecting it to do something it was never intended to do: Protect against infection.
So these points explain why we use boosters over time -
example tetanus antitoxin boosters every 10 years or so.
They also explain the why of inoculation strategies for children.
They explain why it may be possible for Omicron to be less pathogenic.
I'll let you work it out...
